HistoPlexer: Histopathology-based Protein Multiplex Generation using Deep Learning

Sonali Andani,Boqi Chen,Joanna Ficek-Pascual,Simon Heinke,Ruben Casanova,Bernhard Hild,Bettina Sobottka,Bernd Bodenmiller,The Tumor Profiler Consortium,Viktor H Kölzer,Gunnar Rätsch
DOI: https://doi.org/10.1101/2024.01.26.24301803
2024-12-07
Abstract:Multiplexed imaging technologies provide crucial insights into interactions between tumors and their surrounding tumor microenvironment (TME), but their widespread adoption is limited by cost, time, and tissue availability. We introduce HistoPlexer, a deep learning (DL) framework that generates spatially-resolved protein multiplexes directly from histopathology images. HistoPlexer employs the conditional generative adversarial networks with custom loss functions that mitigate slice-to-slice variations and preserve spatial protein correlations. In a comprehensive evaluation on metastatic melanoma samples, HistoPlexer consistently outperforms existing approaches, achieving superior Multiscale Structural Similarity Index and Peak Signal-to-Noise Ratio. Qualitative evaluation by domain experts demonstrates that the generated protein multiplexes closely resemble the real ones, evidenced by Human Eye Perceptual Evaluation error rates exceeding the 50% threshold for perceived realism. Importantly, HistoPlexer preserves crucial biological relationships, accurately capturing spatial co-localization patterns among proteins. In addition, the spatial distribution of cell types derived from HistoPlexer-generated protein multiplex enables effective stratification of tumors into immune hot versus cold subtypes. When applied to an independent cohort, incorporating additional features from HistoPlexer-generated multiplexes enhances the performance of the DL model for survival prediction and immune subtyping, outperforming the model reliant solely on Hematoxylin & Eosin (H&E) image features. By enabling the generation of whole-slide protein multiplex from the H&E image, HistoPlexer offers a cost- and time-effective approach to understanding the TME, and holds promise for advancing precision oncology.
What problem does this paper attempt to address?